Commission Regulation (EU) No 491/2014 of 5 May 2014 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, azoxystrobin, cycloxydim, cyfluthrin, dinotefuran, fenbuconazole, fenvalerate, fludioxonil, fluopyram, flutriafol, fluxapyroxad, glufosinate-ammonium, imidacloprid, indoxacarb, MCPA, methoxyfenozide, penthiopyrad, spinetoram and trifloxystr
2014年5月5日第491/2014号委员会法规(EU)修订了欧洲议会和理事会第396/2005号法规(EC)附件二和附件三 涉及阿米替丁、偶氮菌酯、环氧乙烯啶、氟氰菊酯、二硝基呋喃、芬布康唑、氰戊菊酯、氟二氧嘧啶、氟吡仑、氟三氯甲烷、氟吡草胺、草磷铵、吡虫啉、吲哚恶威、二氯三氯甲烷、 甲氧基非诺齐、戊硫酸钠、斯皮尼托兰和三氟氧西林
Commission Regulation (EU) No 491/2014 of 5 May 2014 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, azoxystrobin, cycloxydim, cyfluthrin, dinotefuran, fenbuconazole, fenvalerate, fludioxonil, fluopyram, flutriafol, fluxapyroxad, glufosinate-ammonium, imidacloprid, indoxacarb, MCPA, methoxyfenozide, penthiopyrad, spinetoram and trifloxystrobin in or on certain products Text with EEA relevance